Life satisfaction in individuals with premenstrual syndrome: Scale development and evaluation of psychometric properties

IF 4.9 2区医学 Q1 CLINICAL NEUROLOGY

Journal of affective disorders Pub Date : 2025-06-23 DOI:10.1016/j.jad.2025.119757

Ahsen Demirhan Kayacik, Kevser Ilcioglu

{"title":"Life satisfaction in individuals with premenstrual syndrome: Scale development and evaluation of psychometric properties","authors":"Ahsen Demirhan Kayacik, Kevser Ilcioglu","doi":"10.1016/j.jad.2025.119757","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Premenstrual syndrome (PMS) is characterized by various physiological and psychological symptoms occurring in the luteal phase of the menstrual cycle, which may negatively affect women's life satisfaction. Existing general life satisfaction scales are insufficient to assess the impact of PMS-specific multidimensional and cyclical symptoms. This study aimed to develop a valid and reliable life satisfaction scale specific to PMS and to identify the individual and environmental factors that influence this satisfaction.</div></div><div><h3>Methods</h3><div>This methodological and cross-sectional study was conducted in two phases. In the first phase (<em>n</em> = 158), a scale development study was carried out; in the second phase (<em>n</em> = 379), the psychometric properties were evaluated. Exploratory and confirmatory factor analyses were used to assess construct validity, while Cronbach's alpha and McDonald's omega coefficients were calculated for reliability. In the second phase of the study, independent samples <em>t</em>-test, ANOVA, Cohen's d, eta-squared, and multiple linear regression analyses were performed.</div></div><div><h3>Results</h3><div>The 15-item scale with three subdimensions demonstrated acceptable fit indices (RMSEA = 0.078; X2/df = 1.96; CFI = 0.91; GFI = 0.88; AGFI = 0.83) and high reliability (α = 0.880; ꞷ = 0.885). Significant associations were found between life satisfaction scores and factors such as employment status, exercise habits, chronic disease diagnosis, and coping methods for PMS (<em>p</em> < 0.05).</div></div><div><h3>Conclusion</h3><div>The PMS-Specific Life Satisfaction Scale is a valid and reliable tool that comprehensively evaluates the impact of PMS on women's life satisfaction and identifies key influencing factors. The findings suggest that lifestyle factors play an important role and can guide personalized care planning.</div></div>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":"388 ","pages":"Article 119757"},"PeriodicalIF":4.9000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165032725011991","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Premenstrual syndrome (PMS) is characterized by various physiological and psychological symptoms occurring in the luteal phase of the menstrual cycle, which may negatively affect women's life satisfaction. Existing general life satisfaction scales are insufficient to assess the impact of PMS-specific multidimensional and cyclical symptoms. This study aimed to develop a valid and reliable life satisfaction scale specific to PMS and to identify the individual and environmental factors that influence this satisfaction.

Methods

This methodological and cross-sectional study was conducted in two phases. In the first phase (n = 158), a scale development study was carried out; in the second phase (n = 379), the psychometric properties were evaluated. Exploratory and confirmatory factor analyses were used to assess construct validity, while Cronbach's alpha and McDonald's omega coefficients were calculated for reliability. In the second phase of the study, independent samples t-test, ANOVA, Cohen's d, eta-squared, and multiple linear regression analyses were performed.

Results

The 15-item scale with three subdimensions demonstrated acceptable fit indices (RMSEA = 0.078; X2/df = 1.96; CFI = 0.91; GFI = 0.88; AGFI = 0.83) and high reliability (α = 0.880; ꞷ = 0.885). Significant associations were found between life satisfaction scores and factors such as employment status, exercise habits, chronic disease diagnosis, and coping methods for PMS (p < 0.05).

Conclusion

The PMS-Specific Life Satisfaction Scale is a valid and reliable tool that comprehensively evaluates the impact of PMS on women's life satisfaction and identifies key influencing factors. The findings suggest that lifestyle factors play an important role and can guide personalized care planning.

查看原文本刊更多论文

经前期综合征个体的生活满意度：量表开发和心理测量特性评估

经前综合征（PMS）是指发生在月经周期黄体期的各种生理和心理症状，可能会对女性的生活满意度产生负面影响。现有的一般生活满意度量表不足以评估经前症候群特有的多维和周期性症状的影响。本研究旨在为经前症候群制定一套有效可靠的生活满意度量表，并探讨影响经前症候群生活满意度的个体因素和环境因素。方法本研究分为两个阶段进行。在第一阶段（n = 158），进行了规模开发研究；在第二阶段（n = 379），评估心理测量特性。采用探索性和验证性因子分析评估结构效度，计算Cronbach's alpha和McDonald's omega系数来评估信度。在研究的第二阶段，进行了独立样本t检验、方差分析、科恩d、平方和多元线性回归分析。结果15题分3个子维度的量表具有可接受的拟合指数(RMSEA = 0.078；X2/df = 1.96；cfi = 0.91；gfi = 0.88；AGFI = 0.83)，信度高(α = 0.880；ꞷ= 0.885)。生活满意度得分与就业状况、运动习惯、慢性病诊断、经前症候群应对方法等因素存在显著相关(p <；0.05)。结论经前症候群生活满意度量表是一种有效、可靠的工具，可以综合评价经前症候群对女性生活满意度的影响，识别关键影响因素。研究结果表明，生活方式因素起着重要作用，可以指导个性化护理计划。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of affective disorders 医学-精神病学

CiteScore

10.90

自引率

6.10%

发文量

1319

审稿时长

9.3 weeks

期刊介绍： The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.